NCT02647697View on ClinicalTrials.gov

Study to Evaluate Properties of Radiprodil Given in Oral Solution to Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Healthy Volunteers

Interventions

DRUG

Radiprodil oral

"* Active Substance: Radiprodil~* Pharmaceutical Form: dry granules for oral suspension~* Concentration: 30 mg~* Route of Administration: oral use"

Trial Locations (1)

Unknown

Up002700001, Groningen

Sponsors

Collaborators (1)

PRA Health Sciences

All Listed Sponsors

collaborator

PRA Health Sciences

INDUSTRY

lead

UCB Biopharma S.P.R.L.

INDUSTRY